Page last updated: 2024-10-16

gamma-aminobutyric acid and TDP-43 Proteinopathies

gamma-aminobutyric acid has been researched along with TDP-43 Proteinopathies in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

TDP-43 Proteinopathies: Diseases characterized by the presence of abnormally phosphorylated, ubiquitinated, and cleaved DNA-binding protein TDP-43 in affected brain and spinal cord. Inclusions of the pathologic protein in neurons and glia, without the presence of AMYLOID, is the major feature of these conditions, thus making these proteinopathies distinct from most other neurogenerative disorders in which protein misfolding leads to brain amyloidosis. Both frontotemporal lobar degeneration and AMYOTROPHIC LATERAL SCLEROSIS exhibit this common method of pathogenesis and thus they may represent two extremes of a continuous clinicopathological spectrum of one disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hebron, M1
Chen, W1
Miessau, MJ1
Lonskaya, I1
Moussa, CE1

Other Studies

1 other study available for gamma-aminobutyric acid and TDP-43 Proteinopathies

ArticleYear
Parkin reverses TDP-43-induced cell death and failure of amino acid homeostasis.
    Journal of neurochemistry, 2014, Volume: 129, Issue:2

    Topics: Amino Acids; Animals; Blotting, Western; Carrier Proteins; Caspase 3; Cell Death; Citric Acid Cycle;

2014